New York, March 14, 2018:

    Spine Biologics Market Forecast 2018 to 2022

    The Global Spine Biologics Market is expected to exceed more than US$ 2.6 Billion by 2022, at a CAGR of 4.4% in the given forecast period.

    The scope of the report includes a detailed study of global and regional markets for Global Spine Biologics Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include DePuy Spine, Precision Spine, Medtronic, Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., Zimmer Spine Inc., K2M, Nuvasive, Arthrex, Inc., DMP Spine, Alphatec Spine, Orthofix Holdings, RTI Surgical, Wright Medical Technology, Cesca Therapeutics, and Lattice Biologics. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    You Can Browse Full Research Report: 

    The Global Spine Biologics Market has been segmented as below:

    By Product Analysis

    • Bone graft substitutes
    • Platelet rich plasma (PRP)
    • Bone grafts
    • Bone marrow aspirates concentrate (BMAC) therapy.

    By Surgery Analysis

    • Anterior cervical discectomy and fusion (ACDF)
    • Anterior lumbar interbody fusion (ALIF)
    • Transforaminal lumbar interbody fusion (TLIF)
    • Lateral lumbar interbody fusion (LLIF)
    • Other surgeries

    By Regional Analysis

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    This report provides:

    1) An overview of the global market for Spine Biologics and related technologies.

    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

    3) Identifications of new market opportunities and targeted promotional plans for Global Spine Biologics Market.

    4) Discussion of research and development, and the demand for new products and new applications.

    5) Comprehensive company profiles of major players in the industry.

    The Global Spine Biologics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    Request Sample Report:


    Table of Contents


    2 Research Methodology

    3 Executive Summary

    4 Market Overview

    5 Spine Biologics Market, By Surgery Type

    5.1 Introduction
    5.2 Anterior Cervical Discectomy and Fusion (ACDF)
    5.3 Posterior Lumbar Interbody Fusion (PLIF)
    5.4 Transforaminal Lumbar Interbody Fusion (TLIF)
    5.5 Anterior Lumbar Interbody Fusion (ALIF)
    5.6 Lateral Lumbar Interbody Fusion (LLIF)
    5.7 Others

    6 Spine Biologics Market By Product Type

    7 Spine Biologics Market, By Geography

    8 Competitive Landscape

    9 Company Profiles

    9.1 Zimmer Holding, Inc.

    9.2 Depuy Synthes

    9.3 Medtronic, Inc. (U.S.)

    9.4 Nuvasive, Inc.

    9.5 Stryker Corporation

    9.6 Orthofix International N.V.

    9.7 K2M, Inc.

    9.8 Exactech, Inc.

    9.9 Wright Medical Technology, Inc.

    9.10 Nutech

    9.11 Arthrex, Inc.

    9.12 X-Spine Systems, Inc. (Bacterin International Holdings, Inc.)

    9.13 DR PRP USA LLC



    Media Contact

    Contact Person: John Bay


    Phone: +1-855-984-1862

    Country: United States